Citation tools
"Preclinical Characterization of ABT-348, a Kinase Inhibitor Targeting the Aurora, Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor, and Src Kinase Families." Journal of Pharmacology and Experimental Therapeutics
343.3
(2012):
617-627.
Web. 19 April. 2024.